August 7, 2024 Experience Revolution Medicines $500 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
August 6, 2024 Experience AC Immune $80 million at-the-market offering We advised AC Immune on the offering
August 6, 2024 Experience Southwest Gas Holdings $340 million at-the-market offering The shares are listed on the New York Stock Exchange
August 2, 2024 Experience MicroStrategy $2 billion at-the-market offering The stock is listed on the Nasdaq Global Select Market
July 26, 2024 Experience PGE $400 million at-the-market offering The common stock is listed on the NYSE
July 19, 2024 Experience Clariane €92 million reserved capital increase and €237 million rights offering We advised Clariane on its refinancing transactions
July 11, 2024 Experience IDEAYA Biosciences $302.5 million equity offering The common stock is listed on the Nasdaq Global Select Market